PEN – Penumbra, Inc.

Penumbra, Inc.

PEN

$256.63

Name : Penumbra, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $9,938,228,224.00

EPSttm : 1.08

Penumbra, Inc.

$256.63

0.08%

$0.2

Float Short %

4.06

Margin Of Safety %

-14

Put/Call OI Ratio

0.19

EPS Next Q Diff

0.13

EPS Last/This Y

3.39

EPS This/Next Y

1.24

Price

256.57

Target Price

316.94

Analyst Recom

1.65

Performance Q

-4.09

Relative Volume

0.5

Beta

0.48

Ticker: PEN

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	PEN	256.06	0.18	0.18	4016
2025-06-03	PEN	257.24	0.18	0.14	4019
2025-06-04	PEN	255.11	0.17	0.11	4039
2025-06-05	PEN	258.5	0.16	0.11	4182
2025-06-06	PEN	259.01	0.16	0.05	4084
2025-06-09	PEN	256.46	0.18	0.21	4139
2025-06-10	PEN	255.54	0.18	0.59	4147
2025-06-11	PEN	252.29	0.18	0.71	4163
2025-06-12	PEN	253.25	0.18	1.08	4151
2025-06-13	PEN	256.46	0.18	0.05	4276
2025-06-16	PEN	260.98	0.18	0.46	4326
2025-06-17	PEN	255.93	0.18	0.24	4374
2025-06-18	PEN	257.18	0.18	0.37	4372
2025-06-20	PEN	256.43	0.17	0.57	4405
2025-06-23	PEN	254.51	0.19	0.10	3927
2025-06-24	PEN	255.74	0.19	0.11	3951
2025-06-25	PEN	253.25	0.19	0.74	3964
2025-06-26	PEN	253.26	0.18	0.00	3960
2025-06-27	PEN	256.41	0.19	0.00	3758
2025-06-30	PEN	256.57	0.19	0.00	3764
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	PEN	256.18	28.4	125.8	3.75
2025-06-03	PEN	257.36	28.4	134.3	3.75
2025-06-04	PEN	255.23	28.4	131.8	3.75
2025-06-05	PEN	258.38	28.4	135.6	3.75
2025-06-06	PEN	258.85	28.4	133.7	3.75
2025-06-09	PEN	256.49	28.4	131.6	3.75
2025-06-10	PEN	255.58	28.4	132.7	3.75
2025-06-11	PEN	253.02	28.4	131.4	3.75
2025-06-12	PEN	253.40	28.4	133.4	3.75
2025-06-13	PEN	256.59	28.4	135.8	3.75
2025-06-16	PEN	260.55	28.4	136.4	3.75
2025-06-17	PEN	256.07	28.4	129.9	3.75
2025-06-18	PEN	257.01	28.4	134.2	3.75
2025-06-20	PEN	256.87	28.4	133.3	3.75
2025-06-23	PEN	254.47	28.4	131.6	3.75
2025-06-24	PEN	255.67	28.4	134.3	3.75
2025-06-25	PEN	253.26	28.4	131.6	3.75
2025-06-26	PEN	253.27	28.4	133.3	3.75
2025-06-27	PEN	256.14	28.4	135.3	3.75
2025-06-30	PEN	256.57	28.4	133.5	3.75
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	PEN	-16.44	-0.63	4.02
2025-06-03	PEN	-16.44	-0.63	4.02
2025-06-04	PEN	-16.26	-0.63	4.02
2025-06-05	PEN	-16.16	-0.63	4.03
2025-06-06	PEN	-16.16	-0.63	4.03
2025-06-09	PEN	-16.16	-0.54	4.03
2025-06-10	PEN	-16.16	-0.54	4.03
2025-06-11	PEN	-16.16	-0.54	3.45
2025-06-12	PEN	-16.16	-0.54	3.45
2025-06-13	PEN	-16.16	-0.54	3.45
2025-06-16	PEN	-17.09	0.28	3.45
2025-06-17	PEN	-17.09	0.28	3.45
2025-06-18	PEN	-17.09	0.28	3.45
2025-06-20	PEN	-17.10	0.28	3.45
2025-06-23	PEN	-16.96	-0.55	3.45
2025-06-24	PEN	-16.09	-0.55	3.45
2025-06-25	PEN	-16.09	-0.55	3.45
2025-06-26	PEN	-16.09	-0.55	4.06
2025-06-27	PEN	-16.09	-0.55	4.06
2025-06-30	PEN	-17.01	-0.54	4.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.83

Avg. EPS Est. Current Quarter

0.82

Avg. EPS Est. Next Quarter

0.96

Insider Transactions

-17.01

Institutional Transactions

-0.54

Beta

0.48

Average Sales Estimate Current Quarter

327

Average Sales Estimate Next Quarter

341

Fair Value

221.02

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

26.4

Max Drawdown 5-Year %

-62.6

Target Price

316.94

P/E

240.7

Forward P/E

51.26

PEG

5.8

P/S

8.01

P/B

8.18

P/Free Cash Flow

66.11

EPS

1.07

Average EPS Est. Cur. Y

3.75

EPS Next Y. (Est.)

4.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.41

Relative Volume

0.5

Return on Equity vs Sector %

-20.4

Return on Equity vs Industry %

-14.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

133.5

Penumbra, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 4500

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

stock quote shares PEN – Penumbra, Inc. Stock Price stock today

news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PEN – Penumbra, Inc. yahoo finance google finance

stock history PEN – Penumbra, Inc. invest stock market

stock prices PEN premarket after hours

ticker PEN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

PEN – Penumbra, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y